Showing results (1-10 of 377) with videos related to
Sort By:
Pageof 38
Current Drug Discovery Technologies|October 26, 2011
Reversing anticoagulant therapyShari Ghanny, Theodore E Warkentin, Mark A CrowtherCanadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|February 1, 2003
Reversing anticoagulants both old and newTheodore E Warkentin, Mark A CrowtherBlood|March 1, 2008
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agentsMark A Crowther, Theodore E WarkentinBlood Advances|February 26, 2020
A practical approach to evaluating postoperative thrombocytopeniaLeslie Skeith, Lisa Baumann Kreuziger, Mark A Crowther, et al.Blood|September 20, 2012
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysisAdam Cuker, Phyllis A Gimotty, Mark A Crowther, et al.Platelets|August 9, 2020
Catastrophic antiphospholipid syndrome refractory to high-dose intravenous immunoglobulin responsive to therapeutic plasma exchangeTyler E James, Leslie J Martin, Theodore E Warkentin, et al.Blood|May 17, 2015
Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndromeTheodore E Warkentin, Richard J Cook, Ravi Sarode, et al.Transfusion|February 13, 2009
Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdoseLorne Holland, Theodore E Warkentin, Majed Refaai, et al.Current Opinion in Hematology|July 16, 2013
Treatment with novel oral anticoagulants: indications, efficacy and risksShari Ghanny, Mark CrowtherBlood|November 20, 2014
Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivitiesTheodore E Warkentin, Jo-Ann I Sheppard, F Victor Chu, et al.Pageof 38